Diabetes, Obesity & Metabolism·9 SepA Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal TolerabilityExperiments in animalsInterventionsPaper